REQUEST A DEMO
Total
USD $0.00
Search more companies

Sdruzene Ordinace Bystrc S.R.O. (Czech Republic)

Main Activities: General Medical and Surgical Hospitals
Full name: Sdruzene Ordinace Bystrc S.R.O. Profile Updated: December 06, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Sdruzene Ordinace Bystrc S.R.O. is an enterprise in Czech Republic, with the main office in Otrokovice. It operates in the General Medical and Surgical Hospitals sector. The company was established on January 19, 2017. 1 - 5 (2023) employees currently work for Sdruzene Ordinace Bystrc S.R.O.. The latest financial highlights indicate a net sales revenue drop of 18.3% in 2023. Its’ total assets recorded a growth of 13.65%. The net profit margin of Sdruzene Ordinace Bystrc S.R.O. increased by 20.73% in 2023.

Headquarters
Dr. Stojana 307
Otrokovice; Zlinsky; Postal Code: 76502

Contact Details: Purchase the Sdruzene Ordinace Bystrc S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Sdruzene Ordinace Bystrc S.R.O. report to view the information.
Outstanding Shares:
Purchase the Sdruzene Ordinace Bystrc S.R.O. report to view the information.
Registered Capital:
Purchase the Sdruzene Ordinace Bystrc S.R.O. report to view the information.
Incorporation Date:
January 19, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Sdruzene Ordinace Bystrc S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-18.3%
Total operating revenue
-18.32%
Operating profit (EBIT)
737.86%
Net Profit (Loss) for the Period
742.17%
Total assets
13.65%
Total equity
202.61%
Operating Profit Margin (ROS)
25.58%
Net Profit Margin
20.73%
Return on Equity (ROE)
42.89%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?